Shares of Hikma Pharmaceuticals PLC HIK slid 1.18% to £20.04 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.20% to 9,120.31 ...

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are ...

The expansion will grow domestic capacity across four sites and support the production of more than 12 billion doses of ...

In the last 15 years, Hikma has asserted itself as one of the U.S.’ top three sterile injectable suppliers by volume, Bill Larkins, Ph.D., president of Hikma Injectables, said in a statement.

Hikma Pharmaceuticals PLC HIK shares rallied 1.73% to £21.12 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.69% to ...

Hikma Pharmaceuticals USA (HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D. Read more details here.

(RTTNews) - Hikma Pharmaceuticals Plc (HIK, HIK.L), on Thursday, reiterated its full-year guidance following a solid start to 2025, highlighting strong performance across its core business segments.